The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNb Global Regulatory News (NBMI)

Share Price Information for Nb Global (NBMI)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 54.60
Bid: 54.60
Ask: 57.60
Change: -0.20 (-0.36%)
Spread: 3.00 (5.495%)
Open: 55.00
High: 55.00
Low: 54.60
Prev. Close: 56.30
NBMI Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Results analysis from Kepler Trust Intelligence

22 Sep 2022 07:00

RNS Number : 2012A
NB Global Monthly Income Fund Ltd
22 September 2022
 

NB Global Monthly Income Fund (NBMI)

22/09/2022

 

Results analysis from Kepler Trust Intelligence

NB Global Monthly Income Fund (NBMI) has reported a NAV total return of -8.92% for the first half of the 2022 financial year, ending 30/06/2022, and a share price total return of -9.27%. During the period fixed income markets saw sell-offs in duration and credit. NBMI's diversified portfolio performed better than the high yield market, the ICE BofA Global High Yield Constrained Index returning -14.88%.

At the beginning of the year the board announced a target dividend of £0.00415 per share per month (5.25% of NAV on an annualised basis). Thanks to increases in central banks' base rates, this target was raised to £0.00443 per share in April or 5.8% of NAV annualised, and then again to 6.75% annualised in July (£0.00467 per share per month).

Kepler View

NB Global Monthly Income Fund (NBMI) is essentially a highly sophisticated strategic bond fund that uses the flexibility afforded by the closed-ended structure to invest in various non-conventional fixed income sectors usually restricted to institutions. This helps the portfolio to generate a high ungeared yield. As of the end of July, the portfolio had 26.3% in private debt, 11.7% in special situations and 11.1% in CLOs, sectors in which the typical bond fund won't or can't invest. A significant proportion of the portfolio is held in leveraged loans (29% at the end of August), which contributes to the floating rate component.

The results for H1 2022 were disappointing in absolute terms as bonds and equities sold off significantly. Having a low duration helped NBMI relative to global bond markets, and floating rate instruments continue to make up the majority of the portfolio, although they have fallen slightly from 70% to 66%. This should provide some cushion against the effects of any further rate increases by central banks, and could lead to corresponding increases in the dividends on offer. The high yield focus of the portfolio detracted from performance, and given 100% of the portfolio had a high yield rating as of 31/07/2022, credit will continue to be a key risk factor in the future. However, the credit exposure brings with it highly attractive income, and the current dividend when annualised amounts to a yield of 7.15% on the current share price (thanks in part to the discount). The manager notes that default rates remain low in high yield, and believes they are likely to remain so based on their bottom-up analysis of issuers.

CLICK HERE TO READ THE FULL REPORT Visit Kepler Trust Intelligence for more high quality independent investment trust research.

Important information

This report has been issued by Kepler Partners LLP. The analyst who has prepared this report is aware that Kepler Partners LLP has a relationship with the company covered in this report and/or a conflict of interest which may impair the objectivity of the research.

Past performance is not a reliable indicator of future results. The value of investments can fall as well as rise and you may get back less than you invested when you decide to sell your investments. It is strongly recommended that if you are a private investor independent financial advice should be taken before making any investment or financial decision.

Kepler Partners is not authorised to make recommendations to retail clients. This report has been issued by Kepler Partners LLP, is based on factual information only, is solely for information purposes only and any views contained in it must not be construed as investment or tax advice or a recommendation to buy, sell or take any action in relation to any investment.

The information provided on this website is not intended for distribution to, or use by, any person or entity in any jurisdiction or country where such distribution or use would be contrary to law or regulation or which would subject Kepler Partners LLP to any registration requirement within such jurisdiction or country. In particular, this website is exclusively for non-US Persons. Persons who access this information are required to inform themselves and to comply with any such restrictions.

The information contained in this website is not intended to constitute, and should not be construed as, investment advice. No representation or warranty, express or implied, is given by any person as to the accuracy or completeness of the information and no responsibility or liability is accepted for the accuracy or sufficiency of any of the information, for any errors, omissions or misstatements, negligent or otherwise. Any views and opinions, whilst given in good faith, are subject to change without notice.

This is not an official confirmation of terms and is not a recommendation, offer or solicitation to buy or sell or take any action in relation to any investment mentioned herein. Any prices or quotations contained herein are indicative only.

Kepler Partners LLP (including its partners, employees and representatives) or a connected person may have positions in or options on the securities detailed in this report, and may buy, sell or offer to purchase or sell such securities from time to time, but will at all times be subject to restrictions imposed by the firm's internal rules. A copy of the firm's Conflict of Interest policy is available on request.

PLEASE SEE ALSO OUR TERMS AND CONDITIONS

Kepler Partners LLP is authorised and regulated by the Financial Conduct Authority (FRN 480590), registered in England and Wales at 70 Conduit Street, London W1S 2GF with registered number OC334771.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained within this announcement is of a non-regulatory nature. Reach announcements are identified with an orange label and the word “Reach” in the source column of the News Explorer pages of London Stock Exchange’s website so that they are distinguished from the RNS UK regulatory service. Other vendors subscribing for Reach press releases may use a different method to distinguish Reach announcements from UK regulatory news.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAZZGZLKMVGZZM
Date   Source Headline
3rd May 20246:00 pmRNSNet Asset Value(s)
2nd May 20246:00 pmRNSNet Asset Value(s)
1st May 20246:00 pmRNSNet Asset Value(s)
1st May 202411:55 amRNSHolding(s) in Company
30th Apr 20246:00 pmRNSNet Asset Value(s)
29th Apr 20246:00 pmRNSNet Asset Value(s)
26th Apr 20246:00 pmRNSNet Asset Value(s)
25th Apr 20246:00 pmRNSNet Asset Value(s)
25th Apr 20244:00 pmRNSDividend Declaration
24th Apr 20246:00 pmRNSNet Asset Value(s)
23rd Apr 20246:00 pmRNSNet Asset Value(s)
22nd Apr 20246:00 pmRNSNet Asset Value(s)
19th Apr 20246:00 pmRNSNet Asset Value(s)
18th Apr 20246:00 pmRNSNet Asset Value(s)
17th Apr 20246:00 pmRNSNet Asset Value(s)
17th Apr 20247:00 amRNSAnnual Financial Report
16th Apr 20246:00 pmRNSNet Asset Value(s)
15th Apr 20246:00 pmRNSNet Asset Value(s)
12th Apr 20246:00 pmRNSNet Asset Value(s)
11th Apr 20246:00 pmRNSNet Asset Value(s)
10th Apr 20246:00 pmRNSNet Asset Value(s)
9th Apr 20246:00 pmRNSNet Asset Value(s)
8th Apr 20246:00 pmRNSNet Asset Value(s)
4th Apr 20246:00 pmRNSNet Asset Value(s)
3rd Apr 20246:00 pmRNSNet Asset Value(s)
2nd Apr 20246:00 pmRNSNet Asset Value(s)
2nd Apr 202410:28 amRNSTotal Voting Rights
28th Mar 20246:00 pmRNSNet Asset Value(s)
27th Mar 20246:00 pmRNSNet Asset Value(s)
26th Mar 20246:00 pmRNSNet Asset Value(s)
25th Mar 20246:00 pmRNSNet Asset Value(s)
22nd Mar 20246:00 pmRNSNet Asset Value(s)
21st Mar 20246:00 pmRNSNet Asset Value(s)
20th Mar 20246:00 pmRNSNet Asset Value(s)
19th Mar 20246:00 pmRNSNet Asset Value(s)
18th Mar 20246:00 pmRNSNet Asset Value(s)
15th Mar 20246:00 pmRNSNet Asset Value(s)
14th Mar 20246:00 pmRNSNet Asset Value(s)
13th Mar 20246:00 pmRNSNet Asset Value(s)
12th Mar 20246:00 pmRNSNet Asset Value(s)
11th Mar 20246:00 pmRNSNet Asset Value(s)
8th Mar 20246:00 pmRNSNet Asset Value(s)
7th Mar 20246:00 pmRNSNet Asset Value(s)
7th Mar 20244:55 pmRNSDirector/PDMR Shareholding
7th Mar 202411:52 amRNSDirector/PDMR Shareholding
6th Mar 20246:00 pmRNSNet Asset Value(s)
5th Mar 20246:00 pmRNSNet Asset Value(s)
5th Mar 20247:00 amRNSReturn of Capital by Partial Compulsory Redemption
4th Mar 20246:00 pmRNSNet Asset Value(s)
1st Mar 20246:00 pmRNSNet Asset Value(s)

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.